BSE Circulars (21849)
Bombay Stock Exchange circulars covering trading rules, listing requirements, compliance guidelines, market operations, and regulatory changes for market participants.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces listing of 25,58,32,190 equity shares of Shah Metacorp Limited issued on preferential basis to promoters and non-promoters, … | |||||||||||||||
BSE announces listing of 25,58,32,190 equity shares of Shah Metacorp Limited issued on preferential basis to promoters and non-promoters, effective December 30, 2025.
| |||||||||||||||
BSE approves listing of 25.58 crore preferential equity shares of Shah Metacorp Limited at Rs. 4.71 per share, with lock-in periods until … | |||||||||||||||
BSE approves listing of 25.58 crore preferential equity shares of Shah Metacorp Limited at Rs. 4.71 per share, with lock-in periods until June 2026 and 2027.
| |||||||||||||||
27,69,000 equity shares of Venmax Drugs And Pharmaceuticals Ltd listed on BSE with effect from December 30, 2025, issued on preferential … | |||||||||||||||
27,69,000 equity shares of Venmax Drugs And Pharmaceuticals Ltd listed on BSE with effect from December 30, 2025, issued on preferential basis pursuant to conversion of warrants.
| |||||||||||||||
27,69,000 equity shares of Venmax Drugs And Pharmaceuticals Ltd listed on BSE with effect from December 30, 2025, issued on preferential … | |||||||||||||||
27,69,000 equity shares of Venmax Drugs And Pharmaceuticals Ltd listed on BSE with effect from December 30, 2025, issued on preferential basis pursuant to conversion of warrants.
| |||||||||||||||
27,69,000 equity shares of Venmax Drugs And Pharmaceuticals Ltd listed on BSE with effect from December 30, 2025, issued on preferential … | |||||||||||||||
27,69,000 equity shares of Venmax Drugs And Pharmaceuticals Ltd listed on BSE with effect from December 30, 2025, issued on preferential basis pursuant to conversion of warrants.
| |||||||||||||||
BSE announces listing of 7,67,407 equity shares of Vivo Bio Tech Ltd. issued on preferential basis pursuant to conversion of warrants, … | |||||||||||||||
BSE announces listing of 7,67,407 equity shares of Vivo Bio Tech Ltd. issued on preferential basis pursuant to conversion of warrants, effective December 30, 2025.
| |||||||||||||||
Listing of 7,67,407 equity shares of Vivo Bio Tech Ltd. issued to non-promoters on preferential basis pursuant to conversion of warrants, … | |||||||||||||||
Listing of 7,67,407 equity shares of Vivo Bio Tech Ltd. issued to non-promoters on preferential basis pursuant to conversion of warrants, effective December 30, 2025.
| |||||||||||||||
BSE notifies listing of commercial paper from 6 companies including 360 ONE Prime Limited, UGRO Capital, DSP Finance, CNH Industrial … | |||||||||||||||
BSE notifies listing of commercial paper from 6 companies including 360 ONE Prime Limited, UGRO Capital, DSP Finance, CNH Industrial Capital, SBICAP Securities, and Himadri Speciality Chemical on debt market segment.
| |||||||||||||||
BSE announces listing of commercial papers from six companies including 360 ONE Prime Limited, UGRO Capital, DSP Finance, CNH Industrial … | |||||||||||||||
BSE announces listing of commercial papers from six companies including 360 ONE Prime Limited, UGRO Capital, DSP Finance, CNH Industrial Capital, SBICAP Securities, and Himadri Speciality Chemical on debt market segment.
| |||||||||||||||
BSE announces the listing of privately placed debt securities of NJ Capital Private Limited on the debt market segment, effective December … | |||||||||||||||
BSE announces the listing of privately placed debt securities of NJ Capital Private Limited on the debt market segment, effective December 29, 2025.
| |||||||||||||||